AU Stock MarketDetailed Quotes
NSB Neuroscientific Biopharmaceuticals Ltd
- 0.036
- -0.001-2.70%
20min DelayNot Open Oct 2 15:59 AET
5.21MMarket Cap18.00P/E (Static)
0.039High0.036Low292.59KVolume0.037Open0.037Pre Close10.72KTurnover0.07852wk High0.28%Turnover Ratio144.60MShares0.03352wk Low0.002EPS TTM3.73MFloat Cap0.540Historical High18.00P/E (Static)103.65MShs Float0.033Historical Low0.002EPS LYR8.11%Amplitude--Dividend TTM0.97P/B1Lot Size--Div YieldTTM
Neuroscientific Biopharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (FY)Jun 30, 2021 | (Q4)Jun 30, 2021 | (FY)Jun 30, 2020 | (Q4)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 0.86%4.95M | 0.86%4.95M | -31.93%4.91M | -31.93%4.91M | -49.05%7.22M | -49.05%7.22M | 330.88%14.16M | 330.88%14.16M | -28.70%3.29M | -28.70%3.29M |
| -Cash and cash equivalents | 0.86%4.95M | 0.86%4.95M | -31.93%4.91M | -31.93%4.91M | -49.05%7.22M | -49.05%7.22M | 330.88%14.16M | 330.88%14.16M | -28.70%3.29M | -28.70%3.29M |
| -Accounts receivable | -77.23%9.9K | -77.23%9.9K | -64.06%43.47K | -64.06%43.47K | 144.82%120.93K | 144.82%120.93K | 158.18%49.4K | 158.18%49.4K | -30.87%19.13K | -30.87%19.13K |
| Total current assets | 0.68%5.04M | 0.68%5.04M | -32.28%5.01M | -32.28%5.01M | -48.72%7.4M | -48.72%7.4M | 336.40%14.43M | 336.40%14.43M | -28.71%3.31M | -28.71%3.31M |
| Non current assets | ||||||||||
| -Goodwill | 41.40%385.31K | 41.40%385.31K | -15.48%272.5K | -15.48%272.5K | -13.41%322.42K | -13.41%322.42K | -11.83%372.35K | -11.83%372.35K | -10.57%422.29K | -10.57%422.29K |
| Regulatory assets | 25.34%54.48K | 25.34%54.48K | -64.06%43.47K | -64.06%43.47K | 144.82%120.93K | 144.82%120.93K | 158.18%49.4K | 158.18%49.4K | -30.87%19.13K | -30.87%19.13K |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| -accounts payable | -85.49%84.93K | -85.49%84.93K | -72.97%585.5K | -72.97%585.5K | 1,132.50%2.17M | 1,132.50%2.17M | 185.36%175.74K | 185.36%175.74K | 42.69%61.59K | 42.69%61.59K |
| -Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Current liabilities | -85.66%85.68K | -85.66%85.68K | -73.06%597.36K | -73.06%597.36K | 892.65%2.22M | 892.65%2.22M | 152.35%223.41K | 152.35%223.41K | 41.70%88.53K | 41.70%88.53K |
| Non current liabilities | ||||||||||
| Non current accrued expenses | -26.53%6.46K | -26.53%6.46K | -47.42%8.79K | -47.42%8.79K | -39.95%16.72K | -39.95%16.72K | 195.10%27.84K | 195.10%27.84K | -31.60%9.44K | -31.60%9.44K |
| Preferred securities outside stock equity | -93.64%754 | -93.64%754 | -77.06%11.86K | -77.06%11.86K | 8.44%51.7K | 8.44%51.7K | 76.90%47.67K | 76.90%47.67K | 39.50%26.95K | 39.50%26.95K |
| Total non current liabilities | -85.66%85.68K | -85.66%85.68K | -73.06%597.36K | -73.06%597.36K | 892.65%2.22M | 892.65%2.22M | 152.35%223.41K | 152.35%223.41K | 41.70%88.53K | 41.70%88.53K |
| Shareholders'equity | ||||||||||
| Share capital | 0.96%25.52M | 0.96%25.52M | 0.00%25.27M | 0.00%25.27M | 0.00%25.27M | 0.00%25.27M | 115.74%25.27M | 115.74%25.27M | 9.42%11.72M | 9.42%11.72M |
| -common stock | 0.96%25.52M | 0.96%25.52M | 0.00%25.27M | 0.00%25.27M | 0.00%25.27M | 0.00%25.27M | 115.74%25.27M | 115.74%25.27M | 9.42%11.72M | 9.42%11.72M |
| Gains losses not affecting retained earnings | -22.24%1.87M | -22.24%1.87M | -15.32%2.41M | -15.32%2.41M | 88.92%2.84M | 88.92%2.84M | 38.85%1.5M | 38.85%1.5M | 70.47%1.08M | 70.47%1.08M |
| Total equity | 2.74%5.44M | 2.74%5.44M | -31.62%5.29M | -31.62%5.29M | -47.82%7.74M | -47.82%7.74M | 296.70%14.83M | 296.70%14.83M | -27.05%3.74M | -27.05%3.74M |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data